# Ernexa Therapeutics Inc.: Form 8-K, filed Mar 20, 2026

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 17:00 ET
- Period: 2026-03-18
- Accession: 0001493152-26-011922
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315226011922/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315226011922/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315226011922/form8-k.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-011922. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.